Skip to main content

Table 2 Serum and urinary levels of interleukins at baseline

From: High urinary interleukin-2 in late post-transplant period portends a risk of decline in kidney allograft function: a preliminary study

Interleukins level Patient groups
eGFR at baseline eGFR decline by 25% at 2 years
Normal eGFR, ≥ 60 mL/min/1.73 m2 (N = 7) Low eGFR, < 60 mL/min/1.73 m2 (N = 23) p No (N = 23) Yes (N = 7) p
IL-8 (pg/mL) 3.00 (1.16–3.87) 3.10 (2.28–5.10) 0.501 3.00 (2.19–3.78) 3.87 (2.30–6.85) 0.360
IL-10 (pg/mL) 2.24 (1.49–3.33) 3.53 (2.24–4.48) 0.061 3.30 (2.24–4.01) 3.87 (1.29–4.55) 0.962
IL-2 (pg/mL) 0.20 (0.16–3.19) 0.20 (0.18–2.34) 0.924 0.64 (0.19–3.19) 0.18 (0.18–0.20) 0.107
IL-8/Cr (pg/mL/mmol/L) 0.21 (0.10–0.39) 0.60 (0.31–2.29) 0.077 0.38 (0.10–0.89) 1.18 (0.21–3.31) 0.190
IL-10/Cr (pg/mL/mmol/L) 0.08 (0.05–0.09) 0.10 (0.07–0.22) 0.118 0.09 (0.07–0.21) 0.08 (0.05–0.17) 0.501
IL-2/Cr (pg/mL/mmol/L) 0.15 (0.06–0.22) 0.25 (0.14–0.74) 0.048 0.20 (0.13–0.36) 0.56 (0.13–2.47) 0.159
  1. IL-2, interleukin 2; IL-8, interleukin 8; IL-10, interleukin 10; Cr, creatinine